Rigel Pharmaceuticals Provides Update on COVID-19 Program
/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that...
Source: prnewswire.com
📰 Tissue Phase News
Tissue Phase News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Tissue Phase. Real-time updates on events, politics, business and more.